UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054943
Receipt number R000062176
Scientific Title Study of Breast Conserving Surgery Using Pectoralis Major Muscle Flap
Date of disclosure of the study information 2024/07/12
Last modified on 2024/07/12 00:51:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of Breast Conserving Surgery Using Pectoralis Major Muscle Flap

Acronym

Study of Breast Conserving Surgery Using Pectoralis Major Muscle Flap

Scientific Title

Study of Breast Conserving Surgery Using Pectoralis Major Muscle Flap

Scientific Title:Acronym

Exploratory Study on Partial Breast Reconstruction Using Pectoralis Major Muscle Flap in Breast Cancer Surgery

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery Plastic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the safety (with a focus on surgical complications and oncological safety including local recurrence rates) and effectiveness (in terms of cosmetic outcomes and improvement in quality of life) of reconstruction using a pedicled pectoralis major muscle flap following partial mastectomy.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety evaluation (adverse event incidence rate)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Pectoralis major muscle flap for partial breast reconstruction

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Female

Key inclusion criteria

1. Patients with primary breast cancer undergoing partial mastectomy at Nakagami Hospital from the approval of the ethics review to March 2026.
2. Patients for whom significant postoperative breast deformity is expected with partial mastectomy alone.

Key exclusion criteria

1. Patients suspected of having pectoralis major muscle invasion based on preoperative MRI or CT scans.
2. Patients who desire full breast reconstruction with silicone implants in the future.
3. Patients with Poland syndrome or pectoralis major muscle defects due to trauma.
4. Patients with uncontrolled underlying diseases.
5. Patients deemed unsuitable by the attending physician.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Ryohei
Middle name
Last name Katsuragi

Organization

Nakagami Hospital

Division name

Breast Surgery

Zip code

904-2195

Address

610 Noborikawa, Okinawa City, Okinawa Prefecture, Japan

TEL

0989391300

Email

katsuragi@nakagami.or.jp


Public contact

Name of contact person

1st name Ryohei
Middle name
Last name Katsuragi

Organization

Nakagami Hospital

Division name

Brest surgery

Zip code

904-2195

Address

610 Noborikawa, Okinawa City, Okinawa Prefecture, Japan

TEL

0989391300

Homepage URL


Email

katsuragi@nakagami.or.jp


Sponsor or person

Institute

Ryohei Katsuragi, Department of Breast surgery, Nakagami Hospital

Institute

Department

Personal name



Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nakagami Hospital

Address

610 Noborikawa, Okinawa City, Okinawa Prefecture, Japan

Tel

0989391300

Email

katsuragi@nakagami.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

中頭病院


Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 06 Month 16 Day

Date of IRB

2024 Year 06 Month 20 Day

Anticipated trial start date

2024 Year 07 Month 12 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 07 Month 12 Day

Last modified on

2024 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062176